Research ExplorerPublicationsPhoto refractive Keratectomy with Adjuvant Application of Mi...

Photo refractive Keratectomy with Adjuvant Application of Mitomycin C

Standard

Photo refractive Keratectomy with Adjuvant Application of Mitomycin C. / Mehlan, Juliane; Steinberg, Johannes; Katz, Toam Rahamim; Linke, Stephan.

In: J Drug Des Res, Vol. 4, No. 5, 16.05.2017, p. 1050.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Mehlan, J, Steinberg, J, Katz, TR & Linke, S 2017, 'Photo refractive Keratectomy with Adjuvant Application of Mitomycin C', J Drug Des Res, vol. 4, no. 5, pp. 1050.

APA

Mehlan, J., Steinberg, J., Katz, T. R., & Linke, S. (2017). Photo refractive Keratectomy with Adjuvant Application of Mitomycin C. J Drug Des Res, 4(5), 1050.

Vancouver

Mehlan J, Steinberg J, Katz TR, Linke S. Photo refractive Keratectomy with Adjuvant Application of Mitomycin C. J Drug Des Res. 2017 May 16;4(5):1050.

Bibtex

@article{39b781bd91f0420c896a00f26c7616ce,
title = "Photo refractive Keratectomy with Adjuvant Application of Mitomycin C",
abstract = "PRK is a refractive surface ablation and is a good option when LASIK is not possible, especially to avoid flap associated complications. After removing the epithelium an excimer laser treatment is performed. Postoperative application of mitomycin C is possible to modulate the wound healing and to reduce the postoperative occurrence of haze. Adverse side effects of MMC are associated with its concentration, time of application and application strategy. In our protocol we apply MMC between 15-30 seconds with a sponge. Especially for difficult treatments, re-treatments or scarred tissue the application of MMC is advisable.",
author = "Juliane Mehlan and Johannes Steinberg and Katz, {Toam Rahamim} and Stephan Linke",
year = "2017",
month = may,
day = "16",
language = "Deutsch",
volume = "4",
pages = "1050",
journal = "J Drug Des Res",
issn = "2379-089X",
number = "5",

}

RIS

TY - JOUR

T1 - Photo refractive Keratectomy with Adjuvant Application of Mitomycin C

AU - Mehlan, Juliane

AU - Steinberg, Johannes

AU - Katz, Toam Rahamim

AU - Linke, Stephan

PY - 2017/5/16

Y1 - 2017/5/16

N2 - PRK is a refractive surface ablation and is a good option when LASIK is not possible, especially to avoid flap associated complications. After removing the epithelium an excimer laser treatment is performed. Postoperative application of mitomycin C is possible to modulate the wound healing and to reduce the postoperative occurrence of haze. Adverse side effects of MMC are associated with its concentration, time of application and application strategy. In our protocol we apply MMC between 15-30 seconds with a sponge. Especially for difficult treatments, re-treatments or scarred tissue the application of MMC is advisable.

AB - PRK is a refractive surface ablation and is a good option when LASIK is not possible, especially to avoid flap associated complications. After removing the epithelium an excimer laser treatment is performed. Postoperative application of mitomycin C is possible to modulate the wound healing and to reduce the postoperative occurrence of haze. Adverse side effects of MMC are associated with its concentration, time of application and application strategy. In our protocol we apply MMC between 15-30 seconds with a sponge. Especially for difficult treatments, re-treatments or scarred tissue the application of MMC is advisable.

UR - https://www.jscimedcentral.com/DrugDesign/drugdesign-4-1050.pdf

M3 - SCORING: Zeitschriftenaufsatz

VL - 4

SP - 1050

JO - J Drug Des Res

JF - J Drug Des Res

SN - 2379-089X

IS - 5

ER -